Brief: MGC Pharmaceuticals Conditionally Raises A$1.24 Million
14/07/2023 02:28
July 14 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* CONDITIONALLY RAISED A$1.24 MILLION
* ISSUE PRICE OF 0.23 AU CENTS PER FUNDRAISING SHARE
Source text for Eikon: ID:nASX7qJxVh
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group